UC's CRISPR Licensees Unbowed By Losing Initial US Patent Office Ruling

The US patent office's initial ruling on CRISPR patents that granted the Broad Institute a victory at the expense of the University of California caps the first major skirmish in what will be a long, drawn-out corporate legal battle.

CRISPR

Round one in the heated patent fight over rights to the genome-editing technology CRISPR/Cas9 has gone to Harvard University's and the Massachusetts Institute of Technology's Broad Institute and its intellectual property licensees, including Editas Medicine Inc. However, the University of California and its licensees says that it is far from beaten and remains confident of an eventual overall victory.

They were reacting to the US Patent and Trademark Office (USPTO) ruling Feb. 15 that said contested patents on the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip